Definitive diagnosis of PAP requires identification of periodic acid-Schiff (PAS)-positive, lipoproteinaceous material within the alveolar spaces on lung biopsy or bronchoalveolar lavage specimens, in conjunction with elevated serum level of anti-GM-CSF autoantibodies [6,12]. Here, CSF2 is linked to pulmonary alveolar proteinosis.